Autonomous Fourier Ptychographic Microscopy (FPM) is a technology widely used in the field of pathology. It is compatible with high resolution and large field-of-view imaging and can observe more image details. Red blood cells play an indispensable role in assessing the oxygen-carrying capacity of the human body and in screening for clinical diagnosis and treatment needs. In this paper, the blood cell data set is constructed based on the FPM system experimental platform. Before training, four enhancement strategies are adopted for the blood cell image data to improve the generalization and robustness of the model. A blood cell detection algorithm based on SCD-YOLOv7 is proposed. Firstly, the C-MP (Convolutional Max Pooling) module and DELAN (Deep Efficient Learning Automotive Network) module are used in the feature extraction network to optimize the feature extraction process and improve the extraction ability of overlapping cell features by considering the characteristics of channels and spatial dimensions. Secondly, through the Sim-Head detection head, the global information of the deep feature map (mean average precision) and the local details of the shallow feature map are fully utilized to improve the performance of the algorithm for small target detection. MAP is a comprehensive indicator for evaluating the performance of object detection algorithms, which measures the accuracy and robustness of a model by calculating the average precision (AP) under different categories or thresholds. Finally, the Focal-EIoU (Focal Extended Intersection over Union) loss function is introduced, which not only improves the convergence speed of the model but also significantly improves the accuracy of blood cell detection. Through quantitative and qualitative analysis of ablation experiments and comparative experimental results, the detection accuracy of the SCD-YOLOv7 algorithm on the blood cell data set reached 92.4%, increased by 7.2%, and the calculation amount was reduced by 14.6 G.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11820308 | PMC |
http://dx.doi.org/10.3390/s25030882 | DOI Listing |
Pediatr Infect Dis J
March 2025
Department of Pediatric Infectious Diseases, University of California, Davis Children's Hospital, Sacramento, California.
Background: Syphilis is re-emerging, with recent increases in congenital infections. While cerebrospinal fluid (CSF) evaluation can inform management, specimen collection requires technical skill and the interpretation of indices is nuanced. We sought to understand the practical value of CSF indices as an evaluation tool among neonates exposed to syphilis in utero.
View Article and Find Full Text PDFBlood
March 2025
Vanderbilt UniversityVanderbilt-Meharry Center of Excellence in Sickle Cell Disease, Nashville, Tennessee, United States.
Recurrent ischemic priapism is a common complication of sickle cell anemia (SCA) and is associated with devastating physical and psychosocial consequences. All previous trials for priapism prevention have failed to demonstrate clear efficacy. We conducted a randomized, controlled, double-blind phase 2 feasibility trial comparing fixed moderate-dose hydroxyurea plus placebo (usual care arm) versus fixed moderate-dose hydroxyurea plus tadalafil (experimental arm) in 64 men (18- 40 years) with at least three episodes of SCA-related priapism in the past 12 months.
View Article and Find Full Text PDFBlood
March 2025
Sungkyunkwan university school of medicine, Samsung Medical Center, Seoul, Korea, Republic of.
This study aimed to assess the efficacy and safety of combining cemiplimab, an anti-PD1 antibody, with isatuximab, an anti-CD38 antibody, in relapsed or refractory extranodal NK/T-cell lymphoma (R/R ENKTL). The hypothesis was that CD38 blockade could enhance the antitumor activity of PD1 inhibitors. Eligible patients received cemiplimab (250 mg on days 1 and 15) and isatuximab (10 mg/kg on days 2 and 16) intravenously every four weeks for six cycles.
View Article and Find Full Text PDFThe development of targeted therapy for patients with multiple myeloma (MM) is hampered by the low frequency of actionable genetic abnormalities. Gain or amplification of chromosome 1q (1q+) is the most frequent arm-level copy number gain in patients with MM and is associated with higher risk of progression and death despite recent therapeutic advances. Thus, developing targeted therapy for MM patients with 1q+ stands to benefit a large portion of patients in need of more effective management.
View Article and Find Full Text PDFHematology
December 2025
Department of Medicine, University of Washington, Seattle, WA, United States.
Introduction: Cases of warm autoimmune hemolytic anemia (wAIHA) often present with life-threatening levels of hemoglobin requiring red blood cell (RBC) transfusion support.
Aim: This literature review assessed the occurrence, safety, effectiveness, and hospitalization burden of RBC transfusions in the management of patients with wAIHA.
Methods: Electronic databases (Embase, MEDLINE) were searched from inception to December 2021 along with additional searches conducted up to March 2024.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!